Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of Selincro as-needed use for alcohol dependence in UK primary care
2013-004688-30Phase 4Completed
- Sponsor
- Lundbeck
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nalmefene in alcohol dependence, sponsored by Lundbeck. Primary endpoint: Reduction in alcohol consumption. Started Apr 2014; status: completed.
02
Drugs
nalmefene
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on 2013-004688-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004688-30.